Thomas Catinazzo, Chief Financial Officer at Relay Therapeutics, Inc. (RLAY), sold 43,328 shares at $7.29 ($316K) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Open-market sale of $316k RLAY by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.29 | 21,664 | $158K | 50.0% |
| 2 | $7.29 | 21,664 | $158K | 50.0% |
| Total | $7.29 avg | 43,328 | $316K | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $350K | — | Filing → |
| RLAY | SELL | 2026-07-30 | $27K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $331K | — | Filing → |